Genomics-based drug design targets the AT-rich malaria parasite: implications for antiparasite chemotherapy

Author： Yanow Stephanie K   Purcell Lisa A   Lee Moses   Spithill Terry W  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.9, 2007-09, pp. : 1267-1272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-Parasite

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 52-52

Bentham Science Publishers

Access to resources Recommend Favorite

Malaria and Leishmaniasis: Current Status of Chemotherapy, New Leads and Targets for Drug Discovery

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 3, 2009-07 ,pp. : 226-267

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Malaria Genomics, Drug Targets, and Drug Resistance (Guest Editor: Xin-zhuan Su)]

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Malaria Genomics, Drug Targets, and Drug Resistance (Guest Editor: Xin-zhuan Su)]

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Rational Drug Design Strategies with Potential to Revolutionize Malaria Chemotherapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 113-143

Bentham Science Publishers

Access to resources Recommend Favorite